In December, an arbitration panel in CIETAC, the subsidiary of ADNRDC in China, ruled Hangzhou Keluoma, an optical accessory retailer to transfer domain name to Chroma Technology Corp. (Chroma Tech), manufacture of world’s finest optical filter.


A panel of three tried the dispute according to UDRP (Uniform Domain Name Dispute Resolution Policy) and decided is confusingly similar to trademark ”Chroma” which Chroma Tech owns in China and in countries around the world; Hangzhou Keluoma has no rights or legitimate interests in respect of the domain name and has registered and has been using the domain name in “bad faith”.


As an optical filter manufacture well known in the industry located in the United States, Chroma Tech had registered trademark “Chroma” on optical filters and accessories of microscopy equipment in China and worldwide and has been using the trademark in China from early 2000. It comes to Chroma Tech’s attention that Hanghzou Keluoma has registered domain name and has been selling chroma’s optical filters since 2016. Knowing that Hanghzou keluoma is not willing to transfer the domain name voluntarily, Chroma filed a complaint with CIETAC.


Mingdun prepared and submitted comprehensive evidence on Hangzhou Keluoma’s lacking rights and legitimate interests and “bad faith” in registering and using the domain name in dispute, as well as powerful rebuttal to Keluoma’s argument of good faith. Specifically, Mingdun argued Hangzhou Keluoma’s lacking rights and legitimate interests by submitting that “Chroma” is neither a phonetic translation of name of the company nor name of any board members; and argued “bad faith” by submitting evidence to show that “Chroma” has long been known in relevant field such as optical accessories and equipment and tightly connected with Chroma Tech whereas Hangzhou Keluoma has been using the “Chroma” trademark on the website linked to the domain name in dispute to attract desired internet traffic for financial gain.


Based on Mingdun’s allegations the panel ruled in favor of Chroma Tech on following rationales: 1) the essential portion of the domain name “Chroma-cn” is confusingly similar to Chroma Tech’s valid trademark “Chroma”; 2) Hangzhou Keluoma failed to proof it has rights or legitimate interests on the domain name; and 3) registration and use of the domain name is in “bad faith” because Chroma is not the phonetic translation of Hangzhou Keluoma and the domain name in dispute has been used to create likelihood of confusion and attract desired internet traffic for financial gain.


It is always important to proof bad faith in domain name disputes. Bad faith can be proofed from several aspects, create likelihood of confusion and attract desired internet traffic for financial gain can be good a choice if complainant is also doing business in the same intended market.


When resolving domain disputes, there are various approaches or courses of action that can be followed to get the registrant of a domain name to transfer it to you. The most suitable approach always depends on the specific circumstances of each domain.


Mingdun always considers the factual circumstances in the context of the applicable law. If you would like to know what is the best approach for the domain name you want, we can provide you with an opinion.



  • Related information More
  • 点击次数: 1000006
    2023 - 12 - 27
    Author:Miao QuMingdun Made a Speech on the Dilemma of Applying the Crime of Concealing the Proceeds of Crime to Diverted Drug CasesOn December 23, 2023, four lawyers from Mingdun Law Firm, including Liu Jinzhu, Zhang Lin, Wang Hui, and Qu Miao, participated in the Second Seminar on the Theory and Practice of Governance of New Types of Crimes as representatives of the members of Beijing Criminology Research Society.This seminar was organized by the Beijing Criminology Research Society, with the theme of "Exploring the Crime Governance System in the New Era and Serving the Rule of Law in the Capital". Superiors from the Supreme Prosecutor's Office, the Supreme Court, the People's Public Security University of China, the Chinese Society of Criminology and other relevant...
  • 点击次数: 1000007
    2023 - 10 - 17
    In September 2022, an insurance company sued our client, an insurance brokerage company as well as a technology company, requiring them to pay the premium collection and claim settlement amount of RMB 3 million.After accepting the entrustment, MingDun patiently listened to the client's briefing on the contract's signing, performance and dispute. Further, our firm carefully reviews the evidence materials of the case, deeply analyzes the evidence materials related to the litigation request, and works with the client to formulate response strategies and actively respond to the litigation. Ultimately, we drafted and submitted a reply and cross-examination opinion to the people's court, but did not participate in the trial.In July 2023, the court ruled that the plaintiff's claim...
  • 点击次数: 1000006
    2023 - 09 - 13
    Recently, MingDun helped our client Novo Nordisk knock out infringing domain names and in Hong Kong. Mingdun successfully prevented the infringer from illegally using Novo Nordisk's goodwill to deceive patients.Our client Novo Nordisk is a world-leading biopharmaceutical company dedicated to human health for the benefit of patients and society with advanced biotechnology. Novo Nordisk's history dates to 1923, and for a hundred years, it has been committed to innovation and lead the field of diabetes. This tradition also gives Novo the experience and ability to help people overcome other serious chronic diseases, such as hemophilia, growth hormone disorders and obesity. Novo Nordisk has about 43,200 employees in 80 countries and regions and provides products and services to more t...
  • 点击次数: 1000008
    2023 - 09 - 11
    Recently, the Market Supervision Administration of Jiujiang City, Jiangxi Province, at the request of MingDun, imposed a fine of CNY 120,000 on the Jiujiang Fuzeyuan Pharmacy for its retail of only 3 boxes of medicines purchased through illegal channels. This case was published as a typical case by Jiangxi Provincial Market Supervision Administration. Details of the case are as follows.In October 2022, MingDun found that the client’s products sold by the Fuzeyuan Pharmacy had actually flowed through the Affiliated Hospital of Jiujiang Medical College. In another word, the client’s products should be at the hand of the patients, and the Fuzeyuan Pharmacy should have purchased the client’s products from illegal channels. The Fuzeyuan Pharmacy should be retailing Diverted Medicine.Under norma...
× WeChat official account
Beijing Mingdun Law Firm
Copyright 2008 - 2020 Beijing Mingdun Law FirmRhino Cloud Provides Enterprise Cloud Services